Loading asset research
Yarrow Bioscience Inc. Common Stock
YARWNasdaq · USD · StocksQuote as of · Exchange session not verified$26.77
+5.00%
Today
YARW
Loading 1D prices…
Market cap
$69.3M
Volume
74.2K
52w high
$44.2852w low
$8.30Company profile
Yarrow Bioscience Inc. Common Stock
Yarrow Bioscience, Inc. operates as a clinical-stage biotechnology company that engages in developing transformative therapies for autoimmune thyroid diseases. The company's candidate, YB-101, is a humanized monoclonal antibody targeting the thyroid-stimulating hormone receptor (TSHR) for the treatment of Graves' disease and thyroid eye disease. The company was incorporated in 2025 and is based in New York, New York.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
NEW HAVEN, CT, United States
Employees
7
Fiscal year end
1231
CIK
1566044
Session & valuation
Open$25.38
Previous close$25.50
Day high$26.94
Day low$24.00
30-day avg. volume83.5K
Outstanding shares2.7M
Diluted EPS-$0.62
Latest annual period
P/E (trailing)-43.19
P/E (forward)-15.72
Price / book—
Beta2.07
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ATHEAlterity Therapeutics Limited American Depositary Shares | $70.1M | — | — | -$1.33 | +10.00% | Buy |
| TENXTenax Therapeutics Inc. Common Stock | $68.1M | $0.00 | — | -$1.34 | +1.64% | Buy |
| PLRXPliant Therapeutics Inc. Common Stock | $66.3M | $0.00 | — | -$2.43 | -4.46% | Sell |
| ACRVAcrivon Therapeutics Inc. Common Stock | $72.9M | $0.00 | — | -$2.02 | -7.10% | Buy |
| GOSSGossamer Bio Inc. Common Stock | $73M | $48.5M | -351.49% | -$0.75 | +11.03% | Hold |